Blasticidin S

Blasticidin S Chemistry

Blasticidin S is an antibiotic that is derived from the bacterium Streptomyces griseochromogenes. It was discovered in the early 1950s and has since been used extensively in biotechnology and molecular biology for the selection of genetically engineered cells. Blasticidin S inhibits protein synthesis by interfering with the function of peptidyl transferase, an enzyme critical to the protein biosynthesis process in both prokaryotes and eukaryotes. Due to its mode of action, blasticidin S is toxic to a wide range of organisms, including bacteria, yeasts, fungi, plants, and animal cells.

Mechanism of Action

Blasticidin S acts by binding to the ribosomes of susceptible cells, specifically interfering with the peptidyl transferase activity of the 23S ribosomal RNA in the 50S subunit of bacterial ribosomes and the equivalent site in eukaryotic 60S ribosomal subunits. This binding disrupts the normal formation of peptide bonds between amino acids, effectively halting the synthesis of new proteins. This inhibition of protein synthesis ultimately leads to cell death, making blasticidin S an effective antibiotic and selection agent.

Uses in Molecular Biology

In molecular biology, blasticidin S is primarily used for the selection and maintenance of cells that have been genetically modified to confer resistance to this antibiotic. This is achieved by introducing a gene that encodes a blasticidin S deaminase enzyme, which detoxifies blasticidin S, into the cells of interest. Only those cells that have successfully integrated and expressed this resistance gene can survive in the presence of blasticidin S, allowing researchers to easily select for genetically modified cells.

Toxicity and Safety

While blasticidin S is invaluable as a selection agent in research settings, its broad toxicity profile necessitates careful handling and disposal. It is toxic to a wide range of living organisms, including humans, where it can cause skin and eye irritation, and if inhaled or ingested, can lead to more severe health issues. Safety protocols in laboratories that use blasticidin S typically include the use of personal protective equipment (PPE) and engineering controls to minimize exposure.

Resistance

Resistance to blasticidin S, as with many antibiotics, can arise through various mechanisms. The most common method in a laboratory setting involves the use of a resistance gene that encodes blasticidin S deaminase. However, in natural and clinical settings, resistance can emerge through mutations in the ribosomal RNA that prevent blasticidin S binding, efflux pumps that remove the antibiotic from the cell, or enzymatic modification of the antibiotic itself.

Conclusion

Blasticidin S remains a powerful tool in the field of molecular biology for the selection of genetically modified organisms. Its broad spectrum of activity and the ease with which resistance can be selectively introduced into organisms of interest make it invaluable for genetic engineering and biotechnological applications. However, its toxicity necessitates careful handling to ensure the safety of those who work with it.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia